Diligence memo · auto-generated · as of July 2, 2026

Keriton, Inc.

Keriton, Inc. looks fair against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

Keriton, Inc. operates in Other Health Care, based in PHILADELPHIA.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Keriton, Inc. has raised $2.2M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.2M on 2022-09-27.

Most recent recorded round closed around 2022-09-27.

Valuation (modeled)modeled

Provath models Keriton, Inc. at approximately $11M (range $984K–$47M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.92× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era. Within the normal band (92% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 35 months.

Last raise 3.8 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 2.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 49% of Other Health Care peers (5377 compared).

Modeled value ranks above 36% of those peers.

Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.